{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T09:12:42Z","timestamp":1778922762587,"version":"3.51.4"},"reference-count":59,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000222","name":"Heart and Stroke Foundation of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000222","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP 142272"],"award-info":[{"award-number":["MOP 142272"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartrhythmopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm O2"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.hroo.2021.08.008","type":"journal-article","created":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T03:03:43Z","timestamp":1639710223000},"page":"733-741","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"PB","title":["Cardioprotective effects of dantrolene in doxorubicin-induced cardiomyopathy in mice"],"prefix":"10.1016","volume":"2","author":[{"given":"Mohammed Ali","family":"Azam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5054-9136","authenticated-orcid":false,"given":"Praloy","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud M.","family":"Bokhari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith","family":"Dadson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beibei","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"Mass\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daoyuan","family":"Si","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Niri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arjun K.","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick F.H.","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheila","family":"Riazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filio","family":"Billia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kumaraswamy","family":"Nanthakumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hroo.2021.08.008_bib1","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10557-016-6711-0","article-title":"Anthracycline chemotherapy and cardiotoxicity","volume":"31","author":"McGowan","year":"2017","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.hroo.2021.08.008_bib2","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1136\/heartjnl-2017-312103","article-title":"Anthracycline cardiotoxicity: an update on mechanisms, monitoring and prevention","volume":"104","author":"Henriksen","year":"2018","journal-title":"Heart"},{"key":"10.1016\/j.hroo.2021.08.008_bib3","first-page":"17","article-title":"Doxorubicin induced heart failure: phenotype and molecular mechanisms","volume":"10","author":"Mitry","year":"2016","journal-title":"Int J Cardiol Heart Vasc"},{"key":"10.1016\/j.hroo.2021.08.008_bib4","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1006\/jmcc.1997.0588","article-title":"Sarcoplasmic reticulum genes are selectively down-regulated in cardiomyopathy produced by doxorubicin in rabbits","volume":"30","author":"Arai","year":"1998","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.hroo.2021.08.008_bib5","first-page":"439","article-title":"Electrolyte and morphologic alterations of myocardium in adriamycin-treated rabbits","volume":"77","author":"Olson","year":"1974","journal-title":"Am J Pathol"},{"key":"10.1016\/j.hroo.2021.08.008_bib6","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1042\/BJ20050285","article-title":"Doxorubicin activates nuclear factor of activated T-lymphocytes and Fas ligand transcription: role of mitochondrial reactive oxygen species and calcium","volume":"389","author":"Kalivendi","year":"2005","journal-title":"Biochem J"},{"key":"10.1016\/j.hroo.2021.08.008_bib7","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/emm.2006.63","article-title":"Doxorubicin-induced reactive oxygen species generation and intracellular Ca2+ increase are reciprocally modulated in rat cardiomyocytes","volume":"38","author":"Kim","year":"2006","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.hroo.2021.08.008_bib8","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12933-020-01040-5","article-title":"Empagliflozin prevents doxorubicin-induced myocardial dysfunction","volume":"19","author":"Sabatino","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.hroo.2021.08.008_bib9","first-page":"S31","article-title":"Statins mediate recovery from chemotheraphy-induced cardiotoxicity","volume":"34","author":"Dadson","year":"2018","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.hroo.2021.08.008_bib10","first-page":"S339","article-title":"Doxorubicin-induced cardiomyopathy: calcium dynamics and ryanodine receptor dysfunction","volume":"16","author":"Azam","year":"2019","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hroo.2021.08.008_bib11","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1161\/CIRCRESAHA.113.301651","article-title":"Mechanisms of altered Ca2+ handling in heart failure","volume":"113","author":"Luo","year":"2013","journal-title":"Circ Res"},{"key":"10.1016\/j.hroo.2021.08.008_bib12","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.yjmcc.2012.03.006","article-title":"Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies","volume":"52","author":"Octavia","year":"2012","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.hroo.2021.08.008_bib13","first-page":"235","article-title":"Preventing the cancer patient of today from becoming the heart failure patient of tomorrow","volume":"1","author":"Derek","year":"2019","journal-title":"JACC Cardiol"},{"key":"10.1016\/j.hroo.2021.08.008_bib14","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1016\/j.jacc.2018.02.049","article-title":"Carvedilol for prevention of chemotherapy-related cardiotoxicity: the CECCY trial","volume":"71","author":"Avila","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2021.08.008_bib15","first-page":"CD003917","article-title":"Cardioprotective interventions for cancer patients receiving anthracyclines","author":"van Dalen","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.hroo.2021.08.008_bib16","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1742-7843.2005.pto_166.x","article-title":"Activity of d,l-alpha-tocopherol (vitamin E) against cardiotoxicity induced by doxorubicin and doxorubicin with cyclophosphamide in mice","volume":"97","author":"Bjelogrlic","year":"2005","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.hroo.2021.08.008_bib17","first-page":"A1155","article-title":"[Dexrazoxane in anthracycline induced cardiotoxicity and extravasation]","volume":"154","author":"Goey","year":"2010","journal-title":"Ned Tijdschr Geneeskd"},{"key":"10.1016\/j.hroo.2021.08.008_bib18","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.jacc.2009.01.065","article-title":"Dantrolene, a therapeutic agent for malignant hyperthermia, markedly improves the function of failing cardiomyocytes by stabilizing interdomain interactions within the ryanodine receptor","volume":"53","author":"Kobayashi","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2021.08.008_bib19","doi-asserted-by":"crossref","first-page":"H818","DOI":"10.1152\/ajpheart.00287.2014","article-title":"Dantrolene suppresses spontaneous Ca2+ release without altering excitation-contraction coupling in cardiomyocytes of aged mice","volume":"307","author":"Domeier","year":"2014","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.hroo.2021.08.008_bib20","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1388-9842(99)00017-3","article-title":"Dantrolene sodium improves the force-frequency relationship and beta-adregenic responsiveness in failing human myocardium","volume":"1","author":"Meissner","year":"1999","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.hroo.2021.08.008_bib21","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.hroo.2020.03.004","article-title":"Chronic dantrolene treatment attenuates cardiac dysfunction and reduces atrial fibrillation inducibility in a rat myocardial infarction heart failure model","author":"Nofi","year":"2020","journal-title":"Heart Rhythm O2"},{"key":"10.1016\/j.hroo.2021.08.008_bib22","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1161\/CIRCULATIONAHA.113.005443","article-title":"Dantrolene improves survival after ventricular fibrillation by mitigating impaired calcium handling in animal models","volume":"129","author":"Zamiri","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2021.08.008_bib23","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.116.004331","article-title":"Effects of late sodium current blockade on ventricular refibrillation in a rabbit model","volume":"10","author":"Azam","year":"2017","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hroo.2021.08.008_bib24","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1111\/jce.13737","article-title":"Essential role of ryanodine receptor 2 phosphorylation in the effect of azumolene on ventricular arrhythmia vulnerability in a rabbit heart model","volume":"29","author":"Si","year":"2018","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hroo.2021.08.008_bib25","doi-asserted-by":"crossref","first-page":"119440","DOI":"10.1016\/j.lfs.2021.119440","article-title":"Anti-arrhythmic and inotropic effects of empagliflozin following myocardial ischemia","volume":"276","author":"Azam","year":"2021","journal-title":"Life Sci"},{"key":"10.1016\/j.hroo.2021.08.008_bib26","doi-asserted-by":"crossref","first-page":"H1388","DOI":"10.1152\/ajpheart.00665.2015","article-title":"A technical review of optical mapping of intracellular calcium within myocardial tissue","volume":"310","author":"Jaimes","year":"2016","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.hroo.2021.08.008_bib27","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.bbrc.2020.01.107","article-title":"Stabilizing cardiac ryanodine receptor prevents the development of cardiac dysfunction and lethal arrhythmia in Ca2+\/calmodulin-dependent protein kinase II\u03b4c transgenic mice","volume":"524","author":"Sufu-Shimizu","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.hroo.2021.08.008_bib28","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.yjmcc.2011.07.016","article-title":"CaMKII-dependent SR Ca leak contributes to doxorubicin-induced impaired Ca handling in isolated cardiac myocytes","volume":"51","author":"Sag","year":"2011","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.hroo.2021.08.008_bib29","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.tranon.2019.12.006","article-title":"Dantrolene attenuates cardiotoxicity of doxorubicin without reducing its antitumor efficacy in a breast cancer model","volume":"13","author":"Todorova","year":"2020","journal-title":"Transl Oncol"},{"key":"10.1016\/j.hroo.2021.08.008_bib30","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1191\/0960327104ht443oa","article-title":"Prevention of acute adriamycin cardiotoxicity by dantrolene in rats","volume":"23","author":"Buyukokuroglu","year":"2004","journal-title":"Hum Exp Toxicol"},{"key":"10.1016\/j.hroo.2021.08.008_bib31","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1007\/978-94-007-2888-2_52","article-title":"Remodeling of calcium handling in human heart failure","volume":"740","author":"Lou","year":"2012","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.hroo.2021.08.008_bib32","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1139\/y94-088","article-title":"Doxorubicin-induced changes in intracellular Ca2+ transients observed in cardiac myocytes isolated from guinea-pig heart","volume":"72","author":"Jiang","year":"1994","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.hroo.2021.08.008_bib33","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/1382-6689(95)00021-6","article-title":"Doxorubicin alters Ca2+ transients but fails to change Ca2+ sensitivity of contractile proteins","volume":"1","author":"Temma","year":"1996","journal-title":"Environ Toxicol Pharmacol"},{"key":"10.1016\/j.hroo.2021.08.008_bib34","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1253\/jcj.62.505","article-title":"Doxorubicin cardiotoxicity: diastolic cardiac myocyte dysfunction as a result of impaired calcium handling in isolated cardiac myocytes","volume":"62","author":"Maeda","year":"1998","journal-title":"Jpn Circ J"},{"key":"10.1016\/j.hroo.2021.08.008_bib35","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1161\/01.RES.76.4.645","article-title":"Effects of doxorubicin on excitation-contraction coupling in guinea pig ventricular myocardium","volume":"76","author":"Wang","year":"1995","journal-title":"Circ Res"},{"key":"10.1016\/j.hroo.2021.08.008_bib36","doi-asserted-by":"crossref","first-page":"H1069","DOI":"10.1152\/ajpheart.01009.2008","article-title":"Slowing of cardiomyocyte Ca2+ release and contraction during heart failure progression in postinfarction mice","volume":"296","author":"Mork","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.hroo.2021.08.008_bib37","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1113\/jphysiol.2006.107227","article-title":"T-tubule disorganization and reduced synchrony of Ca2+ release in murine cardiomyocytes following myocardial infarction","volume":"574","author":"Louch","year":"2006","journal-title":"J Physiol"},{"key":"10.1016\/j.hroo.2021.08.008_bib38","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0092-8674(00)80847-8","article-title":"PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts","volume":"101","author":"Marx","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.hroo.2021.08.008_bib39","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1161\/hh1101.091268","article-title":"Coupled gating between cardiac calcium release channels (ryanodine receptors)","volume":"88","author":"Marx","year":"2001","journal-title":"Circ Res"},{"key":"10.1016\/j.hroo.2021.08.008_bib40","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00424-015-1717-1","article-title":"Functional response of the isolated, perfused normoxic heart to pyruvate dehydrogenase activation by dichloroacetate and pyruvate","volume":"468","author":"Jaimes","year":"2016","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.hroo.2021.08.008_bib41","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1385\/CT:5:3:269","article-title":"Doxorubicin cardiac dysfunction: effects on calcium regulatory proteins, sarcoplasmic reticulum, and triiodothyronine","volume":"5","author":"Olson","year":"2005","journal-title":"Cardiovasc Toxicol"},{"key":"10.1016\/j.hroo.2021.08.008_bib42","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1161\/01.RES.67.2.272","article-title":"Patterns of interaction between anthraquinone drugs and the calcium-release channel from cardiac sarcoplasmic reticulum","volume":"67","author":"Holmberg","year":"1990","journal-title":"Circ Res"},{"key":"10.1016\/j.hroo.2021.08.008_bib43","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1016\/S0024-3205(02)01524-2","article-title":"Doxorubicin directly binds to the cardiac-type ryanodine receptor","volume":"70","author":"Saeki","year":"2002","journal-title":"Life Sci"},{"key":"10.1016\/j.hroo.2021.08.008_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168219","article-title":"Ginkgolide B exerts cardioprotective properties against doxorubicin-induced cardiotoxicity by regulating reactive oxygen species, Akt and calcium signaling pathways in\u00a0vitro and in\u00a0vivo","volume":"11","author":"Gao","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.hroo.2021.08.008_bib45","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.hrthm.2016.09.014","article-title":"Antiarrhythmic effects of dantrolene in human diseased cardiomyocytes","volume":"14","author":"Hartmann","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hroo.2021.08.008_bib46","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/01.RES.86.1.8","article-title":"Mechanism of doxorubicin-induced inhibition of sarcoplasmic reticulum Ca2+-ATPase gene transcription","volume":"86","author":"Arai","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.hroo.2021.08.008_bib47","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1161\/CIRCRESAHA.118.310082","article-title":"Calcium signaling and reactive oxygen species in mitochondria","volume":"122","author":"Bertero","year":"2018","journal-title":"Circ Res"},{"key":"10.1016\/j.hroo.2021.08.008_bib48","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/0167-5273(85)90103-2","article-title":"Adriamycin does have a potentially depressant effect on left ventricular contractility","volume":"7","author":"Singal","year":"1985","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hroo.2021.08.008_bib49","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0014-5793(81)81115-5","article-title":"The cardiotoxic antibiotic doxorubicin inhibits the Na+\/Ca2+ exchange of dog heart sarcolemmal vesicles","volume":"130","author":"Caroni","year":"1981","journal-title":"FEBS Lett"},{"key":"10.1016\/j.hroo.2021.08.008_bib50","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0735-1097(87)80099-2","article-title":"Alterations in left ventricular diastolic function with doxorubicin therapy","volume":"9","author":"Lee","year":"1987","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2021.08.008_bib51","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0014-2999(96)00678-4","article-title":"Effects of dantrolene sodium on intracellular Ca2+-handling in normal and Ca2+-overloaded cardiac muscle","volume":"316","author":"Meissner","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.hroo.2021.08.008_bib52","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1177\/1074248414568194","article-title":"Effects of dantrolene treatment on ventricular electrophysiology and arrhythmogenesis in rats with chronic beta-adrenergic receptor activation","volume":"20","author":"Liu","year":"2015","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.hroo.2021.08.008_bib53","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1161\/01.RES.0000119923.64774.72","article-title":"Sarcoplasmic reticulum calcium content fluctuation is the key to cardiac alternans","volume":"94","author":"Diaz","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.hroo.2021.08.008_bib54","doi-asserted-by":"crossref","first-page":"13650","DOI":"10.1074\/jbc.RA118.003760","article-title":"The cardiac ryanodine receptor, but not sarcoplasmic reticulum Ca2+-ATPase, is a major determinant of Ca2+ alternans in intact mouse hearts","volume":"293","author":"Sun","year":"2018","journal-title":"J Biol Chem"},{"key":"10.1016\/j.hroo.2021.08.008_bib55","first-page":"H1746","article-title":"Abnormal Ca2+i handling is the primary cause of mechanical alternans: study in ferret ventricular muscles","volume":"261","author":"Kihara","year":"1991","journal-title":"Am J Physiol"},{"key":"10.1016\/j.hroo.2021.08.008_bib56","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1054\/jcaf.2001.24122","article-title":"Mechanical alternans in patients with chronic heart failure","volume":"7","author":"Kodama","year":"2001","journal-title":"J Card Fail"},{"key":"10.1016\/j.hroo.2021.08.008_bib57","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1161\/CIRCEP.113.000958","article-title":"Mechanical alternans is associated with mortality in acute hospitalized heart failure: prospective mechanical alternans study (MAS)","volume":"7","author":"Kim","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hroo.2021.08.008_bib58","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1056\/NEJM199506293322602","article-title":"Female sex and higher drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer","volume":"332","author":"Lipshultz","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hroo.2021.08.008_bib59","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/mpo.2950210704","article-title":"Increased risk of cardiac dysfunction after anthracyclines in girls","volume":"21","author":"Silber","year":"1993","journal-title":"Med Pediatr Oncol"}],"container-title":["Heart Rhythm O2"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666501821001628?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666501821001628?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T08:34:20Z","timestamp":1778920460000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666501821001628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":59,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S2666501821001628"],"URL":"https:\/\/doi.org\/10.1016\/j.hroo.2021.08.008","relation":{},"ISSN":["2666-5018"],"issn-type":[{"value":"2666-5018","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardioprotective effects of dantrolene in doxorubicin-induced cardiomyopathy in mice","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm O2","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hroo.2021.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Heart Rhythm Society. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}